Brown Brothers Harriman & CO Danaher Corp Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Danaher Corp stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 15,000 shares of DHR stock, worth $3.57 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

15,000

Previous 15,063 0.42%

Holding current value

$3.57 Million

Previous $3.76 Million 10.79%

% of portfolio

0.03%

Previous 0.03%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$239.25 - $280.76 $15,072 - $17,687	-63 Reduced 0.42%	15,000 $4.17 Million
Q2 2024 Aug 09, 2024	SELL	$235.51 - $267.98 $93,497 - $106,388	-397 Reduced 2.57%	15,063 $3.76 Million
Q1 2024 May 10, 2024	SELL	$224.58 - $256.19 $171,803 - $195,985	-765 Reduced 4.71%	15,460 $3.86 Million
Q4 2023 Feb 12, 2024	SELL	$185.1 - $233.13 $180,102 - $226,835	-973 Reduced 5.66%	16,225 $3.75 Million
Q3 2023 Nov 13, 2023	BUY	$233.08 - $265.59 $179,005 - $203,973	768 Added 4.67%	17,198 $4.27 Million
Q2 2023 Aug 07, 2023	SELL	$224.99 - $256.14 $441,880 - $503,058	-1,964 Reduced 10.68%	16,430 $3.94 Million
Q1 2023 May 11, 2023	BUY	$239.75 - $277.0 $33,085 - $38,226	138 Added 0.76%	18,394 $4.64 Million
Q4 2022 Feb 09, 2023	BUY	$241.42 - $282.29 $51,663 - $60,410	214 Added 1.19%	18,256 $4.85 Million
Q3 2022 Nov 10, 2022	SELL	$247.06 - $1507.4 $269,542 - $1.64 Million	-1,091 Reduced 5.7%	18,042 $4.66 Million
Q2 2022 Aug 11, 2022	BUY	$237.11 - $299.66 $59,277 - $74,915	250 Added 1.32%	19,133 $4.85 Million
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $147,415 - $180,930	-573 Reduced 2.95%	18,883 $5.54 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $13,435 - $15,134	46 Added 0.24%	19,456 $6.4 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $110,789 - $135,299	-407 Reduced 2.05%	19,410 $5.91 Million
Q2 2021 Aug 13, 2021	BUY	$225.08 - $271.69 $256,816 - $309,998	1,141 Added 6.11%	19,817 $5.32 Million
Q1 2021 May 13, 2021	SELL	$212.38 - $245.9 $376,337 - $435,734	-1,772 Reduced 8.67%	18,676 $4.2 Million
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $120,912 - $139,666	569 Added 2.86%	20,448 $4.54 Million
Q3 2020 Nov 16, 2020	SELL	$177.16 - $215.33 $20,727 - $25,193	-117 Reduced 0.59%	19,879 $4.28 Million
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $29,086 - $39,963	226 Added 1.14%	19,996 $3.54 Million
Q1 2020 May 15, 2020	SELL	$121.39 - $169.05 $470,022 - $654,561	-3,872 Reduced 16.38%	19,770 $2.74 Million
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $362,504 - $416,851	-2,716 Reduced 10.3%	23,642 $3.63 Million
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $695,279 - $752,123	5,135 Added 24.2%	26,358 $3.81 Million
Q2 2019 Aug 14, 2019	BUY	$124.88 - $143.73 $17,732 - $20,409	142 Added 0.67%	21,223 $3.03 Million
Q1 2019 May 15, 2019	BUY	$97.62 - $132.29 $34,362 - $46,566	352 Added 1.7%	21,081 $2.78 Million
Q4 2018 Feb 14, 2019	SELL	$94.85 - $109.54 $69,430 - $80,183	-732 Reduced 3.41%	20,729 $2.14 Million
Q3 2018 Nov 14, 2018	BUY	$98.13 - $108.9 $625,186 - $693,801	6,371 Added 42.22%	21,461 $2.33 Million
Q2 2018 Aug 14, 2018	BUY	$96.1 - $103.24 $168,271 - $180,773	1,751 Added 13.13%	15,090 $1.49 Million
Q1 2018 May 14, 2018	SELL	$92.16 - $103.8 $531,671 - $598,822	-5,769 Reduced 30.19%	13,339 $1.31 Million
Q4 2017 Feb 14, 2018	BUY	$85.26 - $94.62 $114,333 - $126,885	1,341 Added 7.55%	19,108 $1.77 Million
Q3 2017 Nov 14, 2017	SELL	$79.29 - $88.45 $13,400 - $14,948	-169 Reduced 0.94%	17,767 $1.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	17,936	17,936 $1.51 Million

Others Institutions Holding DHR

# of Institutions

2,510

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $173B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Danaher Corp Transaction History